Targeting of drugs:
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Tagungsbericht Buch |
Sprache: | English |
Veröffentlicht: |
New York [u.a.]
Plenum Pr.
1982
|
Schriftenreihe: | [NATO advanced study institutes series
Series A, Life sciences] ; 47 |
Schlagworte: | |
Beschreibung: | X, 430 S. Ill. |
ISBN: | 030641001X |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV000255358 | ||
003 | DE-604 | ||
005 | 20190312 | ||
007 | t | ||
008 | 870612s1982 a||| |||| 10||| eng d | ||
020 | |a 030641001X |9 0-306-41001-X | ||
035 | |a (OCoLC)8345947 | ||
035 | |a (DE-599)BVBBV000255358 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-355 |a DE-188 | ||
050 | 0 | |a RM301 | |
050 | 0 | |a RS201.V43 | |
082 | 0 | |a 615/.7 |2 19 | |
084 | |a XI 1805 |0 (DE-625)152978:12911 |2 rvk | ||
245 | 1 | 0 | |a Targeting of drugs |c ed. by Gregory Gregoriadis ... |
264 | 1 | |a New York [u.a.] |b Plenum Pr. |c 1982 | |
300 | |a X, 430 S. |b Ill. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a [NATO advanced study institutes series : Series A, Life sciences] |v 47 | |
650 | 4 | |a Excipients - Congrès | |
650 | 4 | |a Médicaments - Efficacité - Congrès | |
650 | 2 | |a Stupéfiants - administration et posologie | |
650 | 2 | |a Stupéfiants - effets indésirables | |
650 | 4 | |a Drug carriers (Pharmacy) |v Congresses | |
650 | 4 | |a Drug targeting |v Congresses | |
650 | 4 | |a Drugs |x Effectivness |v Congresses | |
650 | 4 | |a Liposomes |v Congresses | |
650 | 4 | |a Liposomes |x administration & dosage | |
650 | 4 | |a Macromolecular Substances | |
650 | 4 | |a Pharmaceutical Preparations |x administration & dosage | |
650 | 4 | |a Vehicles |x administration & dosage | |
650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Zielorgan |0 (DE-588)4205824-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1981 |z Kap Sunion |2 gnd-content | |
689 | 0 | 0 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
689 | 2 | 1 | |a Zielorgan |0 (DE-588)4205824-7 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Gregoriadis, Gregory |d 1937- |0 (DE-588)107725797X |4 edt | |
711 | 2 | |a Advanced Study Institute on Targeting of Drugs |n 1 |d 1981 |c Soúnion |j Sonstige |0 (DE-588)801723-2 |4 oth | |
830 | 0 | |a [NATO advanced study institutes series |v Series A, Life sciences] ; 47 |w (DE-604)BV008911221 |9 47 | |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-000154200 |
Datensatz im Suchindex
_version_ | 1807591575681761280 |
---|---|
adam_text | |
any_adam_object | |
author2 | Gregoriadis, Gregory 1937- |
author2_role | edt |
author2_variant | g g gg |
author_GND | (DE-588)107725797X |
author_facet | Gregoriadis, Gregory 1937- |
building | Verbundindex |
bvnumber | BV000255358 |
callnumber-first | R - Medicine |
callnumber-label | RM301 |
callnumber-raw | RM301 RS201.V43 |
callnumber-search | RM301 RS201.V43 |
callnumber-sort | RM 3301 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | XI 1805 |
ctrlnum | (OCoLC)8345947 (DE-599)BVBBV000255358 |
dewey-full | 615/.7 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.7 |
dewey-search | 615/.7 |
dewey-sort | 3615 17 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Conference Proceeding Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV000255358</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190312</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1982 a||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">030641001X</subfield><subfield code="9">0-306-41001-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)8345947</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000255358</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS201.V43</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.7</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1805</subfield><subfield code="0">(DE-625)152978:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeting of drugs</subfield><subfield code="c">ed. by Gregory Gregoriadis ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Plenum Pr.</subfield><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 430 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">[NATO advanced study institutes series : Series A, Life sciences]</subfield><subfield code="v">47</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Excipients - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Efficacité - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Stupéfiants - administration et posologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Stupéfiants - effets indésirables</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug carriers (Pharmacy)</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug targeting</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Effectivness</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Liposomes</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Liposomes</subfield><subfield code="x">administration & dosage</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Macromolecular Substances</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">administration & dosage</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vehicles</subfield><subfield code="x">administration & dosage</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zielorgan</subfield><subfield code="0">(DE-588)4205824-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1981</subfield><subfield code="z">Kap Sunion</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Zielorgan</subfield><subfield code="0">(DE-588)4205824-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gregoriadis, Gregory</subfield><subfield code="d">1937-</subfield><subfield code="0">(DE-588)107725797X</subfield><subfield code="4">edt</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Advanced Study Institute on Targeting of Drugs</subfield><subfield code="n">1</subfield><subfield code="d">1981</subfield><subfield code="c">Soúnion</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)801723-2</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">[NATO advanced study institutes series</subfield><subfield code="v">Series A, Life sciences] ; 47</subfield><subfield code="w">(DE-604)BV008911221</subfield><subfield code="9">47</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000154200</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1981 Kap Sunion gnd-content |
genre_facet | Konferenzschrift 1981 Kap Sunion |
id | DE-604.BV000255358 |
illustrated | Illustrated |
indexdate | 2024-08-17T00:14:19Z |
institution | BVB |
institution_GND | (DE-588)801723-2 |
isbn | 030641001X |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000154200 |
oclc_num | 8345947 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-188 |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-188 |
physical | X, 430 S. Ill. |
publishDate | 1982 |
publishDateSearch | 1982 |
publishDateSort | 1982 |
publisher | Plenum Pr. |
record_format | marc |
series | [NATO advanced study institutes series |
series2 | [NATO advanced study institutes series : Series A, Life sciences] |
spelling | Targeting of drugs ed. by Gregory Gregoriadis ... New York [u.a.] Plenum Pr. 1982 X, 430 S. Ill. txt rdacontent n rdamedia nc rdacarrier [NATO advanced study institutes series : Series A, Life sciences] 47 Excipients - Congrès Médicaments - Efficacité - Congrès Stupéfiants - administration et posologie Stupéfiants - effets indésirables Drug carriers (Pharmacy) Congresses Drug targeting Congresses Drugs Effectivness Congresses Liposomes Congresses Liposomes administration & dosage Macromolecular Substances Pharmaceutical Preparations administration & dosage Vehicles administration & dosage Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf Zielorgan (DE-588)4205824-7 gnd rswk-swf Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1981 Kap Sunion gnd-content Targeted drug delivery (DE-588)4302415-4 s DE-604 Arzneistoffträger (DE-588)4278196-6 s Wirkstofffreisetzung (DE-588)4190018-2 s Zielorgan (DE-588)4205824-7 s Gregoriadis, Gregory 1937- (DE-588)107725797X edt Advanced Study Institute on Targeting of Drugs 1 1981 Soúnion Sonstige (DE-588)801723-2 oth [NATO advanced study institutes series Series A, Life sciences] ; 47 (DE-604)BV008911221 47 |
spellingShingle | Targeting of drugs [NATO advanced study institutes series Excipients - Congrès Médicaments - Efficacité - Congrès Stupéfiants - administration et posologie Stupéfiants - effets indésirables Drug carriers (Pharmacy) Congresses Drug targeting Congresses Drugs Effectivness Congresses Liposomes Congresses Liposomes administration & dosage Macromolecular Substances Pharmaceutical Preparations administration & dosage Vehicles administration & dosage Arzneistoffträger (DE-588)4278196-6 gnd Zielorgan (DE-588)4205824-7 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
subject_GND | (DE-588)4278196-6 (DE-588)4205824-7 (DE-588)4190018-2 (DE-588)4302415-4 (DE-588)1071861417 |
title | Targeting of drugs |
title_auth | Targeting of drugs |
title_exact_search | Targeting of drugs |
title_full | Targeting of drugs ed. by Gregory Gregoriadis ... |
title_fullStr | Targeting of drugs ed. by Gregory Gregoriadis ... |
title_full_unstemmed | Targeting of drugs ed. by Gregory Gregoriadis ... |
title_short | Targeting of drugs |
title_sort | targeting of drugs |
topic | Excipients - Congrès Médicaments - Efficacité - Congrès Stupéfiants - administration et posologie Stupéfiants - effets indésirables Drug carriers (Pharmacy) Congresses Drug targeting Congresses Drugs Effectivness Congresses Liposomes Congresses Liposomes administration & dosage Macromolecular Substances Pharmaceutical Preparations administration & dosage Vehicles administration & dosage Arzneistoffträger (DE-588)4278196-6 gnd Zielorgan (DE-588)4205824-7 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
topic_facet | Excipients - Congrès Médicaments - Efficacité - Congrès Stupéfiants - administration et posologie Stupéfiants - effets indésirables Drug carriers (Pharmacy) Congresses Drug targeting Congresses Drugs Effectivness Congresses Liposomes Congresses Liposomes administration & dosage Macromolecular Substances Pharmaceutical Preparations administration & dosage Vehicles administration & dosage Arzneistoffträger Zielorgan Wirkstofffreisetzung Targeted drug delivery Konferenzschrift 1981 Kap Sunion |
volume_link | (DE-604)BV008911221 |
work_keys_str_mv | AT gregoriadisgregory targetingofdrugs AT advancedstudyinstituteontargetingofdrugssounion targetingofdrugs |